IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced a summary of 2025 accomplishments and provided guidance for anticipated ...
GenAI has become a key part of coding workflows, but most companies struggle to track its use, let alone its return on investment. Israeli startup Milestone hopes to help with a platform designed to ...
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results